All questions are shown as received by the Trust.
1) Any guidelines, protocols, or position statements issued by Maidstone and Tunbridge Wells NHS Trust concerning the management of ovarian cancer and the use of chemotherapy that were created or modified in response to the COVID-19 pandemic following the 17 March document issued by NHS England. In particular, I’d like a copy of the Trust Priority List drawn up to indicate prioritisation for chemotherapy treatment.
2) Correspondence or communications regarding the development of these guidelines, including any discussions or considerations that influenced their creation.
3) Any data or analysis Local Trust may have conducted on the impact of COVID-19 on ovarian cancer diagnosis, treatment, or support services.
4) Information on how these guidelines were disseminated to healthcare providers and communicated to patients within your Trust.